A Microsphere-Based Vaccine Prevents and Reverses New-Onset Autoimmune Diabetes

Abstract

This novel microsphere formulation represents the first diabetes-suppressive and reversing nucleic acid vaccine that confers an immunoregulatory phenotype to endogenous dendritic cells.